Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

NCT01703169 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT01703169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2012
Completion date
June 30, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate aplastic anemia, severe aplastic anemia, very severe aplastic anemia